BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Albee LJ, Eby JM, Tripathi A, LaPorte HM, Gao X, Volkman BF, Gaponenko V, Majetschak M. α1-Adrenergic Receptors Function Within Hetero-Oligomeric Complexes With Atypical Chemokine Receptor 3 and Chemokine (C-X-C motif) Receptor 4 in Vascular Smooth Muscle Cells. J Am Heart Assoc 2017;6:e006575. [PMID: 28862946 DOI: 10.1161/JAHA.117.006575] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Desantis AJ, Weche M, Enten GA, Gao X, Majetschak M. The Chemokine (C-C Motif) Receptor 2 Antagonist INCB3284 Reduces Fluid Requirements and Protects From Hemodynamic Decompensation During Resuscitation From Hemorrhagic Shock. Critical Care Explorations 2022;4:e0701. [DOI: 10.1097/cce.0000000000000701] [Reference Citation Analysis]
2 Enten GA, Gao X, Strzelinski HR, Weche M, Liggett SB, Majetschak M. α1B/D-adrenoceptors regulate chemokine receptor-mediated leukocyte migration via formation of heteromeric receptor complexes. Proc Natl Acad Sci U S A 2022;119:e2123511119. [PMID: 35537053 DOI: 10.1073/pnas.2123511119] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Albee LJ, Gao X, Majetschak M. Plasticity of seven-transmembrane-helix receptor heteromers in human vascular smooth muscle cells. PLoS One 2021;16:e0253821. [PMID: 34166476 DOI: 10.1371/journal.pone.0253821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Gao X, Enten GA, DeSantis AJ, Majetschak M. Class A G protein-coupled receptors assemble into functional higher-order hetero-oligomers. FEBS Lett 2021;595:1863-75. [PMID: 34032285 DOI: 10.1002/1873-3468.14135] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Zhang J, Simpson PC, Jensen BC. Cardiac α1A-adrenergic receptors: emerging protective roles in cardiovascular diseases. Am J Physiol Heart Circ Physiol 2021;320:H725-33. [PMID: 33275531 DOI: 10.1152/ajpheart.00621.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gao X, Cheng YH, Enten GA, DeSantis AJ, Gaponenko V, Majetschak M. Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (CXC motif) receptor 4. J Biol Chem 2020;295:14893-905. [PMID: 32839271 DOI: 10.1074/jbc.RA120.015355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
7 Babu FS, Liang X, Enten GA, DeSantis AJ, Volkman BF, Gao X, Majetschak M. Natural and engineered chemokine (C-X-C motif) receptor 4 agonists prevent acute respiratory distress syndrome after lung ischemia-reperfusion injury and hemorrhage. Sci Rep 2020;10:11359. [PMID: 32647374 DOI: 10.1038/s41598-020-68425-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Gao X, Enten GA, DeSantis AJ, Volkman BF, Gaponenko V, Majetschak M. Characterization of heteromeric complexes between chemokine (C-X-C motif) receptor 4 and α1-adrenergic receptors utilizing intermolecular bioluminescence resonance energy transfer assays. Biochem Biophys Res Commun 2020;528:368-75. [PMID: 32085899 DOI: 10.1016/j.bbrc.2020.02.094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
9 Eby JM, Majetschak M. Effects of ethanol and ethanol metabolites on intrinsic function of mesenteric resistance arteries. PLoS One 2019;14:e0214336. [PMID: 30893362 DOI: 10.1371/journal.pone.0214336] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
10 Albee LJ, LaPorte HM, Gao X, Eby JM, Cheng YH, Nevins AM, Volkman BF, Gaponenko V, Majetschak M. Identification and functional characterization of arginine vasopressin receptor 1A : atypical chemokine receptor 3 heteromers in vascular smooth muscle. Open Biol 2018;8:170207. [PMID: 29386406 DOI: 10.1098/rsob.170207] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
11 Gao X, Abdelkarim H, Albee LJ, Volkman BF, Gaponenko V, Majetschak M. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3. PLoS One 2018;13:e0204041. [PMID: 30248140 DOI: 10.1371/journal.pone.0204041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
12 Brown SM, Meuth AI, Davis JW, Rector RS, Bender SB. Mineralocorticoid receptor antagonism reverses diabetes-related coronary vasodilator dysfunction: A unique vascular transcriptomic signature. Pharmacol Res 2018;134:100-8. [PMID: 29870805 DOI: 10.1016/j.phrs.2018.06.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
13 Gao X, Albee LJ, Volkman BF, Gaponenko V, Majetschak M. Asymmetrical ligand-induced cross-regulation of chemokine (C-X-C motif) receptor 4 by α1-adrenergic receptors at the heteromeric receptor complex. Sci Rep 2018;8:2730. [PMID: 29426850 DOI: 10.1038/s41598-018-21096-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
14 Cheng YH, Eby JM, LaPorte HM, Volkman BF, Majetschak M. Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function. PLoS One 2017;12:e0187949. [PMID: 29125867 DOI: 10.1371/journal.pone.0187949] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]